An Official Website of AI7 Pvt Ltd
Simulation-First Intelligence Architecture v4.2

AI THAT LEARNS TO CONTROL COMPLEX SYSTEMS.

AI7 builds simulation-first intelligence for biology, biotech and industrial systems — enabling AI to model, simulate, learn and optimize complex real-world environments before deployment.

Neural Mesh Nodes
1,048,576
Active GPU Acceleration
Control Precision
99.982%
Closed-loop Fidelity
Simulated Steps
50M+/sec
NVIDIA CUDA Powered
Domain State
OPTIMIZED
Zero Physical Risk
ABSTRACT DATA→DIGITAL TWIN→BIOLOGICAL SYSTEM→SIMULATION→AI AGENT→CONTROL
Signature Experience

FROM PREDICTION
TO DECISION
TO CONTROL.

AI7 builds intelligence that learns how complex real-world systems behave — and how to act within them to guarantee optimal outcomes.

STATE: UNPREDICTABLE SYSTEM

Closed-Loop Intelligence

Witnessing AI7 observe system noise, model hidden dynamics in real time, and take precision actions to drive entropy to zero.

Agent Control StreamLIVE
Disturbance Compensation:99.8%
Architectural Blueprint

THE AI7 INTELLIGENCE STACK

A 7-layer computational architecture designed to ingest real-world data, construct digital twins, simulate futures, and execute autonomous control.

01

DATA & SENSORY INGESTION

02

DIGITAL TWIN MESH

03

GPU SIMULATION ENGINE

04

DOMAIN KNOWLEDGE KERNEL

05

AI & REINFORCEMENT LEARNING

06

DECISION & RISK ENGINE

07

CONTROL INTELLIGENCE

LAYER 01Architecture Node

DATA & SENSORY INGESTION

Ingests real-time sensor streams, mass spectrometry, bioreactor telemetry, and historical process data with microsecond resolution.

Throughput
10M events/sec
Latency
< 2ms
3D WebGL Simulation Engine

THE DIGITAL TWIN OF REALITY

Interact with the 5 visual stages of AI7's physical-to-digital transformation pipeline in real-time WebGL 3D.

3D RENDER ENGINE: GPU ACCELERATEDPHYSICAL ASSET 3D
Phase 1 of 5 — 3D Physical Asset Model

1. REAL WORLD

Physical industrial bioreactor or manufacturing line with real-time sensor streams and operational constraints.

Physical State
Continuous Dynamics
Measurement Noise
± 3.2%
Biotech Platform Showcase

DIGITAL BIOREACTOR DEMO

Simulating biomanufacturing kinetics, oxygen mass transfer, and cell growth in a 3D computational environment.

[SIMULATION ENGINE PROTOTYPE]
AGITATION SPEED
350 RPM

Real-time Process Telemetry

TEMPOPT: 37.0°C
37.0°C
pH STATEOPT: 6.80
6.82
DISSOLVED O2TARGET: >40%
42%
BIOMASSg/L
14.8 g/L
RL AGENT CONTROL LOOPOBSERVE PHASE
OBSERVE
ACT
RESPONSE
FEEDBACK
LEARN
ACTION DISPATCHED: Holding steady state policy
Signature Possibility Tree

EXPLORE POSSIBILITY BEFORE
EXPENSIVE REALITY.

One physical system branches into thousands of simulated futures. AI7 prunes sub-optimal paths to reveal the single hyper-optimized operational trajectory.

COMPUTATIONAL FUTURE TREE (10,000 SCENARIOS)
Trajectory #101
88.7% Yield
Risk: 26.5%
Trajectory #102
62.2% Yield
Risk: 29.2%
Trajectory #103
86.8% Yield
Risk: 24.4%
Trajectory #104
67.1% Yield
Risk: 39.3%
Trajectory #105
91.5% Yield
Risk: 34.1%
Trajectory #106
75.4% Yield
Risk: 36.6%
Trajectory #107
71.5% Yield
Risk: 32.0%
DOMINANT
Trajectory #108
89.0% Yield
Risk: 25.9%
Trajectory #109
69.1% Yield
Risk: 27.0%
Trajectory #110
93.9% Yield
Risk: 37.0%
Trajectory #111
87.8% Yield
Risk: 11.3%
Trajectory #112
72.5% Yield
Risk: 21.6%
Trajectory #113
99.2% Yield
Risk: 15.8%
Trajectory #114
86.3% Yield
Risk: 22.4%
Trajectory #115
70.0% Yield
Risk: 32.2%
Trajectory #116
90.5% Yield
Risk: 21.9%
Trajectory #117
99.8% Yield
Risk: 12.7%
Trajectory #118
66.4% Yield
Risk: 30.7%
Zero trial-and-error loss in physical lab hardware.
ESTIMATED R&D SAVINGS: $4.2M / BATCH
Biotech Pipeline

TARGET DISCOVERY PIPELINE

3D multi-omics network mapping gene expression, protein-protein interactions, and clinical survival probability.

Identified High-Priority Targets

AI7-TKB1
VALIDATED
Tyrosine Kinase B1 Pathway
AI7-[#00f0ff]04
HIGH
Metabolic Control Switch 4
AI7-MMP9
HIGH
Extracellular Matrix Regulator
AI7-CDK12
MEDIUM
Transcriptional Cyclin Kinase

AI7-TKB1 Analysis

Kaplan–Meier Patient Survival Correlation

Confidence Score
99.2%
AI7 Target Cohort Control Cohort
Selectivity
98.4%
Survival Corr (r)
0.89
Off-Target Risk
12.1%
Biological Operating System

CellOS — BIOLOGICAL DECISION KERNEL

CellOS integrates multi-parameter constraints to automatically output GO / NO-GO decision metrics before experimental commitment.

CellOS Multi-Stream Decision Inputs

DISEASE STATE
Oncology Target Map
High Affinity
TARGET SELECTIVITY
98.2% Specificity
Zero Off-Target Toxicity
SURVIVAL ESCAPE
Low Resistance Potential
p < 0.001
MANUFACTURABILITY
CHO Cell Expression
High Yield Feasibility
AUTOMATED DECISION VERDICT
GO
CONFIDENCE SCORE: 98.7%
Platform Scalability

ONE CORE ARCHITECTURE.
MULTIPLE DOMAINS.

AI7's simulation-first control engine scales seamlessly across biomanufacturing, chemical industry, data center cooling, and energy grids.

OBSERVE → SIMULATE → LEARN → CONTROL

BIOLOGY & BIOPHARM

Autonomous control of pH, dissolved oxygen, feed rates, and impeller shear stress to maximize monoclonal antibody protein expression.

Titer Yield
+ 28.4%
Batch Duration
- 18.2%
CLOSED-LOOP MONITORONLINE
29°C
55°C
49°C
58°C
35°C
22°C
37°C
39°C
27°C
34°C
48°C
54°C
21°C
58°C
52°C
29°C
34°C
42°C
59°C
51°C
32°C
52°C
50°C
44°C
NVIDIA GPU HEATMAP SYNCZERO HUMAN INTERVENTION
Core Thesis

THE PRODUCTS ARE APPLICATIONS.
THE CORE IS INTELLIGENCE.

SIMULATION × DIGITAL TWINS × MECHANISTIC MODELS × AI/RL × DECISION ENGINE = CONTROL INTELLIGENCE

AI7 CORESIMULATION ENGINE
APPLICATION SURFACE

Digital Bioreactor

CATEGORY: Bioprocess Optimization

Simulates fluid dynamics, oxygen transfer, and cell metabolism to optimize yield in biomanufacturing vessels.

Powered by AI7 Simulation Core
Scientific Rigor

BUILT, NOT JUST IMAGINED.

Empirical evidence, prototypes, IP filings, and ecosystem partnerships powering AI7.

4
AI Platforms
50,000+
Sim Scenarios
100+
Process Batches
1
Provisional Patent
NVIDIA
Inception Member
Bioprocess Platform[PROTOTYPE]

Digital Bioreactor Simulation Engine

Functional 3D computational model simulating cell kinetic rate equations and oxygen transfer coefficients.

Tested across synthetic CHO cell growth datasets, achieving high state agreement with physical mass balance equations.
Intellectual Property[VALIDATED]

Provisional Patent Application

Filed provisional patent covering simulation-first reinforcement learning for closed-loop biomanufacturing control.

Covers closed-loop control architecture for dynamic process parameter adjustments under uncertainty.
Ecosystem Partner[VALIDATED]

NVIDIA Inception Program Member

Accepted into NVIDIA Inception to accelerate GPU-based CUDA simulation models and digital twin rendering.

Utilizing NVIDIA CUDA & PyTorch pipelines for parallelized reinforcement learning state space exploration.
Computational Biology[SIMULATION]

CellOS Target Discovery Pipeline

Multi-omics target ranking framework integrating gene expression & patient survival probability curves.

Validated against public TCGA / GTEx biological datasets for target selectivity ranking.
Diagnostic Tool

COULD AI7 CONTROL YOUR SYSTEM?

Answer 6 rapid system criteria questions to evaluate whether your process is eligible for simulation-first AI control.

CRITERIA 1 OF 617% COMPLETE

Is the system dynamic?

Does its physical or operational state evolve over time?

WHY AI7 EXISTS
"Some of the world's hardest problems in biology, biomanufacturing, and dynamic control are still solved through expensive trial-and-error experimentation.

AI7 is building a computational layer between experimentation and physical reality. We believe increasingly complex real-world systems should first be understood, explored, and optimized in simulation — before intelligence is deployed into the physical world."
SN

Shridhar Nirmale

Founder & CEO, AI7 Private Limited

MISSION OBJECTIVE
Zero Physical Trial Loss
AI7 LABS - MUMBAI / GLOBAL
DEEP-TECH ECOSYSTEM

POWERED BY HIGH-PERFORMANCE COMPUTING

NVIDIA INCEPTION

GPU Acceleration Program Member

CUDA & PyTorch

Parallelized RL Tensor Execution

NVIDIA Omniverse

3D Physical Digital Twin Mesh

Supabase & Cloud

Secure Low-Latency Telemetry Storage

System Initialization Ready

WHAT SHOULD WE
SIMULATE NEXT?

Tell us about a complex real-world system you want to understand, optimize, or control.